Meeting of the Tick-Borne Disease Working Group, 19950-19951 [2020-07438]

Download as PDF 19950 Federal Register / Vol. 85, No. 69 / Thursday, April 9, 2020 / Notices organizations that have novice level experience with federal grants. The purpose of the SEDS–GO FOA is to provide financial assistance to tribes and Native American organizations with limited capacity, staff, and resources to compete for federal funding. The funding is to be used to enhance their internal capacity and infrastructure to better serve their members or their communities. Awards made under the FOA will have either a 12-, 24-, or 36month project period with an award ceiling of $200,000, per budget period. Although it is not required to have a 3year project, the funding opportunity will allow the flexibility for 1 year of planning and 2 years of project implementation. ANA is interested in funding eligible entities that have limited experience in managing federal grants due to their limited ability to prepare grant applications, administer projects, evaluate results, or have limited financial management capacity. Bonus points will be provided during the objective review process for applicants that have never received an ANA grant award. The SEDS–GO FOA will request potential applicants to submit a Letter of Intent within 30 days of its publication, but this is not mandatory. The application submission deadline will be 60 days from the date the SEDS–GO FOA is published. Applicants will identify up to two organizational challenges that will be addressed within the following program areas of interest: Staff Development; Governance; Effective Grants Management; Strategic/Community Planning; Financial Management Systems; Use of Technology; Ability to Track and Manage Data; and Partnerships. The ANA Project Framework will not be applicable to SEDS–GO FOA. Applicants will identify up to two targeted challenges within the Program Areas of Interest; a Project Goal; Objectives that are Specific, Measurable, Achievable, Relevant, and Time-Bound (SMART); and an Indicator of change. ANA proposes the following Evaluation criteria scores for the SEDS– GO FY 2020: khammond on DSKJM1Z7X2PROD with NOTICES Evaluation criteria Approach, including Objectives Organizational Capacity .......... Budget and Budget Justification. Bonus Points ........................... Maximum point values 70 points. 15 points. 15 points. 16:28 Apr 08, 2020 Jkt 250001 Elizabeth Leo, Senior Grants Policy Specialist, Office of Administration, Administration for Children and Families. [FR Doc. 2020–07488 Filed 4–8–20; 8:45 am] BILLING CODE 4184–34–P DEPARTMENT OF HEALTH OF HUMAN SERVICES Request for Information—Pandemic and All-Hazards Preparedness and Advancing Innovation Act Section 209; Extension of Comment Period Office of Infectious Disease and HIV/AIDS Policy, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. AGENCY: ACTION: Notice; extension of comment period. The Office of the Assistant Secretary for Health published a document in the Federal Register of March 23, 2020 requesting public comment related to Section 209 of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Due to requests of an extension to the public comment period, this document is announcing an extension. SUMMARY: To be assured consideration, comments must be received at the address provided below no later than midnight Eastern Standard Time (EST) on June 21, 2020. DATES: 5 points. Bonus points will only be awarded if the applicant organization has never received an ANA grant award. Bonus VerDate Sep<11>2014 points will not be awarded in a range— the application will either receive 0 or 5 points. All Administrative Policies included in ANA’s other FY 2020 FOAs will be applicable to the SEDS–GO FOA. The following statements are applicable to the ANA Commissioner’s discretion as part of the ANA internal review process for the selection of applications submitted in response to the SEDS–GO FOA: In exercising discretion in award selection, the Commissioner may choose not to fund a project if ANA has information outside the application that contradicts the justification for the need for the project. The Commissioner may choose not to fund any proposed project that is outside the scope of the listed program areas of interest. In addition, the Commissioner may choose not to fund a project from an applicant that has received more than two ANA grant awards within the last 10 years. Statutory Authority: Section 814 of the Native American Programs Act of 1974 (NAPA), as amended. PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 FOR FURTHER INFORMATION CONTACT: Mr. James Berger, (202) 795–7608; ACBTSA@hhs.gov. Dated: April 3, 2020. James J. Berger, Senior Advisor for Blood and Tissue Policy, Office of the Assistant Secretary for Health. [FR Doc. 2020–07442 Filed 4–8–20; 8:45 am] BILLING CODE 4150–28–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Tick-Borne Disease Working Group Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: As required by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the Tick-Borne Disease Working Group (TBDWG) will hold a meeting. The meeting will be open to the public. For this meeting, the TBDWG will review the work of the Public Comment and Federal Inventory Subcommittees and the chapters being developed for the 2020 report to Congress on federal tick-borne activities and research. DATES: The meeting will be held online via webcast on April 27, 2020, from 9:00 a.m. to 12:30 p.m. ET (times are tentative and subject to change). The confirmed times and agenda items for the meeting will be posted on the TBDWG web page at https:// www.hhs.gov/ash/advisory-committees/ tickbornedisease/meetings/2020-4-27/ index.html when this information becomes available. FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS Policy, Office of the Assistant Secretary for Health, Department of Health and Human Services, Mary E Switzer Building, 330 C Street SW, Suite L600, Washington, DC 20024. Email: tickbornedisease@ hhs.gov; Phone: 202–795–7608. SUPPLEMENTARY INFORMATION: Please register for the virtual meeting at https://kauffmaninc.adobeconnect.com/ tbdwg_apr2020/event/event_info.html. After registering, you will receive an email confirmation with a personalized link to access the webcast on April 27. The public will have an opportunity to present their views to the TBDWG orally during the meeting’s public comment session or by submitting a SUMMARY: E:\FR\FM\09APN1.SGM 09APN1 Federal Register / Vol. 85, No. 69 / Thursday, April 9, 2020 / Notices written public comment. Comments should be pertinent to the meeting discussion. Persons who wish to provide verbal or written public comment should review instructions at https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/meetings/ 2020-4-27/ and respond by midnight April 19, 2020, ET. Verbal comments will be limited to three minutes each to accommodate as many speakers as possible during the 30 minute session. Written public comments will be accessible to the public on the TBDWG web page prior to the meeting. Background and Authority: The TickBorne Disease Working Group was established on August 10, 2017, in accordance with Section 2062 of the 21st Century Cures Act, and the Federal Advisory Committee Act, 5 U.S.C. App., as amended, to provide expertise and review federal efforts related to all tickborne diseases, to help ensure interagency coordination and minimize overlap, and to examine research priorities. The TBDWG is required to submit a report to the HHS Secretary and Congress on their findings and any recommendations for the federal response to tick-borne disease every two years. Dated: March 30, 2020. James J. Berger, Senior Advisor for Blood and Tissue Policy, Office of the Assistant Secretary for Health. [FR Doc. 2020–07438 Filed 4–8–20; 8:45 am] BILLING CODE 4150–28–P A. Overview of Information Collection DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–7033–N–01] 60-Day Notice of Proposed Information Collection: Application for Healthy Homes and Lead Hazard Control Grant Programs and Quality Assurance Plans—OMB Control No. 2539–0015 Office of Lead Hazard Control and Healthy Homes, HUD. ACTION: Notice. AGENCY: HUD is seeking approval from the Office of Management and Budget (OMB) for the information collection described below. In accordance with the Paperwork Reduction Act, HUD is requesting comment from all interested parties on the proposed collection of information. The purpose of this notice is to allow for 60 days of public comment. khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: DATES: Comments Due Date: June 8, 2020. VerDate Sep<11>2014 16:28 Apr 08, 2020 Interested persons are invited to submit comments regarding this proposal. Comments should refer to the proposal by name and/or OMB Control Number and should be sent to: Anna Guido, Reports Management Officer, QDAM, Department of Housing and Urban Development, 451 7th Street SW, Room 4176, Washington, DC 20410–5000; telephone 202–402–3400 (this is not a toll-free number) or email at Anna.P.Guido@hud.gov for a copy of the proposed forms or other available information. Persons with hearing or speech impairments may access this number through TTY by calling the tollfree Federal Relay Service at (800) 877– 8339. FOR FURTHER INFORMATION CONTACT: Anna Guido, Reports Management Officer, QDAM, Department of Housing and Urban Development, 451 7th Street SW, Washington, DC 20410; email Anna Guido at Anna.P.Guido@hud.gov or telephone 202–402–3400. This is not a toll-free number. Persons with hearing or speech impairments may access this number through TTY by calling the tollfree Federal Relay Service at (800) 877– 8339. Copies of available documents submitted to OMB may be obtained from Ms. Guido. SUPPLEMENTARY INFORMATION: This notice informs the public that HUD is seeking approval from OMB for the information collection described in Section A. ADDRESSES: Jkt 250001 Title of Information Collection: Application for Healthy Homes and Lead Hazard Control Grant Programs and Quality Assurance Plans. OMB Approval Number: 2539–0015. Type of Request: Renewal with some changes due to program changes. Form Numbers: SF 424, SF 424, HUD–424CBW, HUD–27061, HUD– 2880, HUD–2991, HUD–96008, HUD– 96011, SF–LLL, HUD–96012, HUD– 96013, HUD–96014, HUD–96015. Description of the need for the information and proposed use: Applications for Lead-Based Paint Hazard Reduction, Healthy Homes Technical Studies, Lead Technical Studies, Older Adult Home Modification Program, and Healthy Homes and Weatherization Cooperation Demonstration grants, and quality assurance plans for those technical studies grants. Respondents: Cities, States and municipalities, universities, private companies. Estimated Number of Respondents: 380. PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 19951 Estimated Number of Responses: 874. Frequency of Response: Annual. Average Hours per Response: 60. Total Estimated Burdens: 30,600 hours, $1,515,924. B. Solicitation of Public Comment This notice is soliciting comments from members of the public and affected parties concerning the collection of information described in Section A on the following: (1) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond; including through the use of appropriate automated collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. HUD encourages interested parties to submit comment in response to these questions. C. Authority Section 3507 of the Paperwork Reduction Act of 1995, 44 U.S.C. Chapter 35. The Director of the Office of Lead Hazard Control and Healthy Homes, Matthew Ammon, having reviewed and approved this document, is delegating the authority to electronically sign this document to Nacheshia Foxx, who is the Federal Register Liaison for HUD, for purposes of publication in the Federal Register. Dated: April 6, 2020. Nacheshia Foxx, Senior Clearance Officer for the Office of Regulations, Office of the General Counsel. [FR Doc. 2020–07465 Filed 4–8–20; 8:45 am] BILLING CODE 4210–67–P DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–7027–N–10; OMB Control No. 2502–0590] 60-Day Notice of Proposed Information Collection: Delegated Processing for Certain Capital Advance Projects Office of the Assistant Secretary for Housing- Federal Housing Commissioner, HUD. ACTION: Notice. AGENCY: E:\FR\FM\09APN1.SGM 09APN1

Agencies

[Federal Register Volume 85, Number 69 (Thursday, April 9, 2020)]
[Notices]
[Pages 19950-19951]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-07438]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Tick-Borne Disease Working Group

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As required by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the Tick-Borne Disease Working Group (TBDWG) will hold a meeting. 
The meeting will be open to the public. For this meeting, the TBDWG 
will review the work of the Public Comment and Federal Inventory 
Subcommittees and the chapters being developed for the 2020 report to 
Congress on federal tick-borne activities and research.

DATES: The meeting will be held online via webcast on April 27, 2020, 
from 9:00 a.m. to 12:30 p.m. ET (times are tentative and subject to 
change). The confirmed times and agenda items for the meeting will be 
posted on the TBDWG web page at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2020-4-27/ when this 
information becomes available.

FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal 
Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS 
Policy, Office of the Assistant Secretary for Health, Department of 
Health and Human Services, Mary E Switzer Building, 330 C Street SW, 
Suite L600, Washington, DC 20024. Email: [email protected]; 
Phone: 202-795-7608.

SUPPLEMENTARY INFORMATION: Please register for the virtual meeting at 
https://kauffmaninc.adobeconnect.com/tbdwg_apr2020/event/event_info.html. After registering, you will receive an email 
confirmation with a personalized link to access the webcast on April 
27.
    The public will have an opportunity to present their views to the 
TBDWG orally during the meeting's public comment session or by 
submitting a

[[Page 19951]]

written public comment. Comments should be pertinent to the meeting 
discussion. Persons who wish to provide verbal or written public 
comment should review instructions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2020-4-27/ and respond 
by midnight April 19, 2020, ET. Verbal comments will be limited to 
three minutes each to accommodate as many speakers as possible during 
the 30 minute session. Written public comments will be accessible to 
the public on the TBDWG web page prior to the meeting.
    Background and Authority: The Tick-Borne Disease Working Group was 
established on August 10, 2017, in accordance with Section 2062 of the 
21st Century Cures Act, and the Federal Advisory Committee Act, 5 
U.S.C. App., as amended, to provide expertise and review federal 
efforts related to all tick-borne diseases, to help ensure interagency 
coordination and minimize overlap, and to examine research priorities. 
The TBDWG is required to submit a report to the HHS Secretary and 
Congress on their findings and any recommendations for the federal 
response to tick-borne disease every two years.

    Dated: March 30, 2020.
James J. Berger,
Senior Advisor for Blood and Tissue Policy, Office of the Assistant 
Secretary for Health.
[FR Doc. 2020-07438 Filed 4-8-20; 8:45 am]
 BILLING CODE 4150-28-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.